Search Results

• • 13 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• 21-Gene recurrence score and locoregional recurrence in node-positive/ER-positive breast cancer treated with chemo-endocrine therapy

  Authors:Eleftherios P. Mamounas, Qing Liu, Soonmyung Paik, Frederick L. Baehner, Gong Tang, Jong-Hyeon Jeong, et al.From:Journal of the National Cancer Institute (Vol. 109, Issue 4) Peer-Reviewed

  Apr. 17, 2017308 words Author abstract, Rep...

   Abstract Only

• Burdensome research procedures in trials: why less is more

  Authors:Jonathan Kimmelman, David B. Resnik, Jeffrey Peppercorn, and Mark J. RatainFrom:Journal of the National Cancer Institute (Vol. 109, Issue 4) Peer-Reviewed

  Apr. 17, 2017127 words Author abstract, Rep...

   Abstract Only

• Surrogate end points for overall survival in loco-regionally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis

  Authors:Federico Rotolo, Jean-Pierre Pignon, Jean Bourhis, Sophie Marguet, Julie Leclercq, Wai Tong Ng, et al.From:Journal of the National Cancer Institute (Vol. 109, Issue 4) Peer-Reviewed

  Apr. 17, 2017290 words Author abstract, Rep...

   Abstract Only

• Sequential validation of blood-based protein biomarker candidates for early-stage pancreatic cancer

  Authors:Michela Capello, Leonidas E. Bantis, Ghislaine Scelo, Yang Zhao, Peng Li, Dilsher S. Dhillon, et al.From:Journal of the National Cancer Institute (Vol. 109, Issue 4) Peer-Reviewed

  Apr. 17, 2017308 words Author abstract, Rep...

   Abstract Only

• Prognostic significance of venous thromboembolic events in disseminated germ cell cancer patients

  Authors:Enrique Gonzalez-Billalabeitia, Daniel Castellano, Nora Sobrevilla, Josep Guma, David Hervas, Maria I. Luengo, et al.From:Journal of the National Cancer Institute (Vol. 109, Issue 4) Peer-Reviewed

  Apr. 17, 2017327 words Author abstract, Rep...

   Abstract Only

• Multigene expression assay and benefit of radiotherapy after breast conservation in ductal carcinoma in situ

  Authors:Eileen Rakovitch, Sharon Nofech-Mozes, Wedad Hanna, Rinku Sutradhar, Frederick L. Baehner, Dave P. Miller, et al.From:Journal of the National Cancer Institute (Vol. 109, Issue 4) Peer-Reviewed

  Apr. 17, 2017271 words Author abstract, Rep...

   Abstract Only

• Hodgkin lymphoma: current status and clinical trial recommendations

  Authors:Catherine S. Diefenbach, Joseph M. Connors, Jonathan W. Friedberg, John P. Leonard, Brad S. Kahl, Richard F. Little, et al.From:Journal of the National Cancer Institute (Vol. 109, Issue 4) Peer-Reviewed

  Apr. 17, 2017120 words Author abstract, Rep...

   Abstract Only

• Germline mutations in the Kallikrein 6 region and predisposition for aggressive prostate cancer

  Authors:Laurent Briollais, Hilmi Ozcelik, Jingxiong Xu, Maciej Kwiatkowski, Emilie Lalonde, Dorota H. Sendorek, et al.From:Journal of the National Cancer Institute (Vol. 109, Issue 4) Peer-Reviewed

  Apr. 17, 2017302 words Author abstract, Rep...

   Abstract Only

• Role of antigen spread and distinctive characteristics of immunotherapy in cancer treatment

  Authors:James L. Gulley, Ravi A. Madan, Russell Pachynski, Peter Mulders, Nadeem A. Sheikh, James Trager, et al.From:Journal of the National Cancer Institute (Vol. 109, Issue 4) Peer-Reviewed

  Apr. 17, 2017251 words Author abstract, Rep...

   Abstract Only

• History of keratinocyte carcinoma and risk of melanoma: a prospective cohort study

  Authors:Shaowei Wu, Eunyoung Cho, Wen-Qing Li, and Abrar A. QureshiFrom:Journal of the National Cancer Institute (Vol. 109, Issue 4) Peer-Reviewed

  Apr. 17, 2017280 words Author abstract, Rep...

   Abstract Only

• Advancing symptom science through symptom cluster research: expert panel proceedings and recommendations

  Authors:Christine Miaskowski, Andrea Barsevick, Ann Berger, Rocco Casagrande, Patricia A. Grady, Paul Jacobsen, et al.From:Journal of the National Cancer Institute (Vol. 109, Issue 4) Peer-Reviewed

  Apr. 17, 2017250 words Author abstract, Rep...

   Abstract Only

• Thinking critically about classifying adverse events: incidence of pancreatitis in patients treated with nivolumab + ipilimumab

  Authors:Claire F. Friedman, Varina Clark, Andrew V. Raikhel, Tim Barz, Alexander N. Shoushtari, Parisa Momtaz, et al.From:Journal of the National Cancer Institute (Vol. 109, Issue 4) Peer-Reviewed

  Apr. 17, 2017187 words Author abstract, Rep...

   Abstract Only

• Current state of PCR-based Epstein-Barr virus DNA testing for nasopharyngeal cancer

  Authors:Kelly Y. Kim, Quynh-Thu Le, Sue S. Yom, Benjamin A. Pinsky, Scott V. Bratman, Raymond H.W. Ng, et al.From:Journal of the National Cancer Institute (Vol. 109, Issue 4) Peer-Reviewed

  Apr. 17, 2017157 words Author abstract, Rep...

   Abstract Only